Cancellations and suspensions

Regulatory action due to , effective 17/12/2024

Regulatory action due to incorrect certification under paragraph 26A(2)(a) of the Act (paragraph 30(1)(e) of the Act), the medicine is not eligible for listing, in accordance with paragraph 30(1A)(a) of the Act.

Cancelled from the ARTG under 30(1C) of the Act

Regulatory action due to The sponsor failed to comply within 20 working days after a notice was given under section 31.

Regulatory action due to The sponsor failed to comply within 20 working days after a notice was given under section 31.

Regulatory action due to The medicine is not eligible for listing (paragraph 30(1A)(a) of the Act).

Regulatory action due to The sponsor failed to comply within 14 days after the end of the period specified in a notice under section 31 of the Act requiring it to provide information or documents relating to the goods., effective 21/12/2022

Regulatory action due to The sponsor has refused or failed to comply with a condition to which the inclusion of the goods is subject (paragraph 30(2)(c) of the Act).

Regulatory action due to The sponsor has refused or failed to comply with a condition to which the inclusion of the goods is subject (paragraph 30(2)(c) of the Act).

Regulatory action due to The certification made by the sponsor under paragraph 26A(2)d) of the Act was incorrect (paragraph 30(2)(ba) of the Act).

Regulatory action due to As it appeared to the Secretary that the medicine's label contained an indication that was not proposed to be accepted in relation to the inclusion of the medicine in the Register, the certification made under s.26A(2)(fba) of the Act was incorrect.It appeared to the Secretary that a statement made in, or in connection with, the application for listing of the goods was false or misleading in a material particular.The sponsor failed to comply with a condition of listing under s.28(5)(ab) of the Act (that the goods will not be advertised for an indication other than those accepted in the Register)., effective 16/05/2022

Regulatory action due to The sponsor has refused or failed to comply with a condition to which the inclusion of the goods is subject (paragraph 30(2)(c) of the Act).The goods do not comply with an applicable provision of the Therapeutic Goods Advertising Code (paragraph 30(2)(ea) of the Act).The presentation of the listed goods is unacceptable (paragraph 30(2)(aa) of the Act)., effective 28/02/2022

Regulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 07/01/2022

Regulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 21/12/2021

Regulatory action due to The presentation of the listed goods is unacceptable (paragraph 30(2)(aa) of the Act).The certification under paragraph 26A(2)(ja) of the Act is incorrect (paragraph 30(2)(ba) of the Act)., effective 23/07/2021

Regulatory action due to The sponsor failed to comply within 20 working days after a notice was given under section 31 requiring it to provide information or documents about the certifications made in relation to the goods., effective 23/03/2021

Regulatory action due to The certification under paragraph 26A(2)(ja) is incorrect (paragraph 30(2)(ba) of the Act).The presentation of the listed goods is unacceptable (paragraph 30(2)(aa) of the Act).The goods do not conform to a requirement relating to advertising applicable to the goods under Part 5-1 or the regulations (paragraph 30(2)(ea) of the Act)., effective 22/01/2021

Regulatory action due to The certification under paragraphs 26A(2)(j) and 26A(2)(ja) of the Act is incorrect (paragraph 30(2)(ba) of the Act).The presentation of the listed goods is unacceptable (paragraph 30(2)(aa) of the Act)., effective 15/01/2021

Regulatory action due to It appeared to the Secretary that a statement made in, or in connection with, the application for listing of the goods was false or misleading in a material particular. As there was insufficient evidence to support the indications for the product, the certification made under s.26A(2)(ja) of the Act was incorrect. It appeared to the Secretary that the presentation of the goods was unacceptable., effective 23/12/2020

Regulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 22/10/2020

Regulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 22/10/2020

Regulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 22/10/2020

Regulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 22/10/2020

Regulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 22/10/2020

Regulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable., effective 22/10/2020